HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]
HC Wainwright reissued their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $12.00 target price on the stock. Anixa Biosciences Price Performance Shares of Anixa Biosciences stock opened at $4.08 on Thursday. Anixa Biosciences has a fifty-two week […]
By Sabela Ojea Shares of Anixa Biosciences climbed 14% to $4.47 in after-hours trading after the company presented positive results regarding its Phase 1.